Cytokine networks during HIV infection: Shifting the balance

Cytokine and Growth Factor Reviews

Volumn 23, Issue 4-5, 2012, Pages 139-141

  Haddad, Elias K ^a   Hiscott, John ^a  

^a VGTI Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR7; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 7; PROGRAMMED DEATH 1 RECEPTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; B LYMPHOCYTE; CD4 CD8 RATIO; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOREGULATION; IMMUNOTHERAPY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; VIRUS LATENCY; VIRUS PATHOGENESIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CYTOKINES; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; SIGNAL TRANSDUCTION; VIRUS LATENCY;

EID: 84864954283     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2012.05.012     Document Type: Editorial

References (13)

1. Barre-Sinoussi F., Chermann J.C., Rey F., Nugeyre M.T., Chamaret S., Gruest J., et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220:868-871.
2. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine 2006, 12:1365-1371.
3. Douek D. HIV disease progression: immune activation, microbes, and a leaky gut. Topics in HIV Medicine 2007, 15:114-117.
4. van Grevenynghe J., Halwani R., Chomont N., Ancuta P., Peretz Y., Tanel A., et al. Lymph node architecture collapse and consequent modulation of FOXO3a pathway on memory T- and B-cells during HIV infection. Seminars in Immunology 2008, 20:196-203.
5. van Grevenynghe J., Procopio F.A., He Z., Chomont N., Riou C., Zhang Y., et al. Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. Nature Medicine 2008, 14:266-274.
6. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354.
7. Kaufmann D.E., Walker B.D. PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. Journal of Immunology 2009, 182:5891-5897.
8. + T cells leads to reversible immune dysfunction. Nature Medicine 2006, 12:1198-1202.
9. Moir S., Ho J., Malaspina A., Wang W., DiPoto A.C., O'Shea M.A., et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. Journal of Experimental Medicine 2008, 205:1797-1805.
10. Titanji K., De Milito A., Cagigi A., Thorstensson R., Grutzmeier S., Atlas A., et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006, 108:1580-1587.
11. van Grevenynghe J., Cubas R.A., Noto A., DaFonseca S., He Z., Peretz Y., et al. Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis. Journal of Clinical Investigation 2011, 121:3877-3888.
12. Abb J., Kochen M., Deinhardt F. Interferon production in male homosexuals with the acquired immune deficiency syndrome (AIDS) or generalized lymphadenopathy. Infection 1984, 12:240-242.
13. Feldman S., Stein D., Amrute S., Denny T., Garcia Z., Kloser P., et al. Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clinical Immunology 2001, 101:201-210.